Skip to Main Content

Paper Details

Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
J Cancer Res Clin Oncol
1
2023
HNSCC, PD-1, PD-L1, RM-, RM-HNSCC, RNA, anti- PD-1, anti-PD-1, formalin, head and neck squamous cell carcinoma, head and neck squamous-cell carcinoma, patient, patients, tumor
Author NameAffiliation
William H WestraIcahn School of Medicine at Mount Sinai
Howard L McLeod
Howard L McLeod
Ezra E W Cohenuniversity of california san diego Moores Cancer Center
  • 1 - 4

Datasets

Release 1.2